App-Quantinova.ai

Impact of brisk walking on cognitive decline in adults with and without early impairment: A FLAME analysis in the PROTECT cohort

Helen Brooker - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer’s Disease.

Henne Holstege - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase 1b Study of Lumbar Intrathecal Bolus Administrations of Antisense Oligonucleotide (ISIS 814907; BIIB080) Targeting Tau mRNA in Patients with Mild Alzheimer’s Disease

Catherine J Mummery - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Assessing the cumulative impact of Vascular Burden on Structural Changes in the Brain during Ageing

Srijan Konwar - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

From brain volumes to subgroup classification in genetic mutation carriers for frontotemporal dementia: a cluster analysis in the GENFI study

Martina Bocchetta - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

Impact of Polygenic Risk Score on Normative Models of Hippocampal Volumes

Mohammed Janahi - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Neuroanatomical signatures of genetic risk for Alzheimer's Disease in healthy adults

Sheena Waters - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Tools for Harmonization of Data in World-Wide FINGERS

Jennifer W Talton - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

CAN ENGAGEMENT IN SOCIALLY AND COGNITIVELY STIMULATING LEISURE ACTIVITIES COMPENSATE FOR OTHER DEMENTIA RISK FACTORS? A PROSPECTIVE COHORT STUDY

Lukas Duffner - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Development of a healthy lifestyle index within a multidomain intervention aimed at prevention of cognitive impairment and dementia, and its association with cognition: results from the FINGER trial.

Mariagnese Barbera - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Feasibility of treating hearing loss to prevent dementia in MCI: results of the face to face and remote interventions in the Treating Auditory impairment and Cognition Trial (TACT)

Sergi Costafreda Gonzalez - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dementia

N/A

Lifelong music practice as reserve factor: Associations with cognition and brain structure in older adults

Miranka Wirth - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Subjective cognitive decline and self-reported sleep at a memory clinic: the SCIENCe project

Heleen M.A. Hendriksen - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

White matter hyperintensities

N/A

Experiences of Black, Asian and minority ethnic persons with dementia and caregivers during COVID-19 in the UK

Emily West - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dementia

N/A

Exploring the experiences of living at risk of familial frontotemporal dementia

Caroline V Greaves - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

“Exploring trust in Black, Asian and minority ethnic persons with dementia and their caregivers: The impact of COVID-19”

Emily West - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dementia

N/A

Factors associated with disclosing a diagnosis of dementia to one’s social network: A systematic review

Gianna Kohl - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Study protocol: SOcial LImitations Turn Up DEmentia (SOLITUDE) Impact of COVID-19 social isolation on patients’ cognition and mental health and on carers’ wellbeing.

Riccardo Manca - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Alzheimer's disease

N/A

The persistence and longitudinal impacts of sleep disturbances in nursing home residents with dementia

Lucy A Webster - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Baseline plasma total tau predicts longitudinal cognitive and functional decline in aging adults

Corey J Bolton - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Filters

45280 Abstracts